Basis: Trailing twelve months (TTM). Source: stored company filings and market data; unavailable inputs remain N/A.
Is the interest coverage ratio high or low?
The interest coverage ratio of -4606.42x is 1858% below its 5-year average of -235.29x, near the high end of its 5-year range (-1415111.00x–-1.10x).
98.70% above its 12-month average of -354904.72x.
Reported quarterly interest coverage; no daily interpolation. Q1 FY2026 (2026-03-31): -2025.86x.
INTEREST COVERAGE RATIO
-4606.42x
INTEREST COVERAGE RATIO AVG TTM
-354904.72x
INTEREST COVERAGE RATIO AVG 3Y
-741.73x
INTEREST COVERAGE RATIO AVG 5Y
-235.29x
INTEREST COVERAGE RATIO AVG 10Y
N/A
INTEREST COVERAGE RATIO AVG 15Y
N/A
INTEREST COVERAGE RATIO AVG 20Y
N/A
CURRENT VS TTM AVG
+98.70%
CURRENT VS 3Y AVG
-521.04%
CURRENT VS 5Y AVG
-1857.73%
CURRENT VS 10Y AVG
N/A
CURRENT VS 15Y AVG
N/A
CURRENT VS 20Y AVG
N/A
SECTOR MEDIAN · HEALTHCARE
-6.38x
median of 528 covered companies
CURRENT VS SECTOR MEDIAN
-72157.57%
vs the sector median at left
iSpecimen Inc.
Market Cap
$2.75M
Interest Coverage Ratio
-4606.42x
TTM Avg
-354904.72x
3Y Avg
-741.73x
5Y Avg
-235.29x
Market Cap
$2.81M
Interest Coverage Ratio
-12.57x
TTM Avg
108.30x
3Y Avg
87.65x
5Y Avg
87.65x
Market Cap
$2.62M
Interest Coverage Ratio
-1.05x
TTM Avg
65.98x
3Y Avg
65.98x
5Y Avg
65.98x
Market Cap
$2.55M
Interest Coverage Ratio
-238.27x
TTM Avg
N/A
3Y Avg
N/A
5Y Avg
N/A
Market Cap
$2.97M
Interest Coverage Ratio
N/A
TTM Avg
N/A
3Y Avg
N/A
5Y Avg
N/A
Market Cap
$2.97M
Interest Coverage Ratio
-7.53x
TTM Avg
56.70x
3Y Avg
56.70x
5Y Avg
56.70x
Market Cap
$2.49M
Interest Coverage Ratio
-81.61x
TTM Avg
N/A
3Y Avg
N/A
5Y Avg
N/A
Market Cap
$2.47M
Interest Coverage Ratio
673.25x
TTM Avg
673.25x
3Y Avg
673.25x
5Y Avg
673.25x
Market Cap
$3.07M
Interest Coverage Ratio
N/A
TTM Avg
N/A
3Y Avg
N/A
5Y Avg
N/A
| NAME | MARKET CAP | INTEREST COVERAGE RATIO | TTM | 3Y | 5Y |
|---|---|---|---|---|---|
| iSpecimen Inc. (ISPC) | $2.75M | -4606.42x | -354904.72x | -741.73x | -235.29x |
| Universe Pharmaceuticals Inc. (UPC)vs › | $2.81M | -12.57x | 108.30x | 87.65x | 87.65x |
| Nuwellis, Inc. (NUWE)vs › | $2.62M | -1.05x | 65.98x | 65.98x | 65.98x |
| bioAffinity Technologies, Inc. (BIAF)vs › | $2.55M | -238.27x | N/A | N/A | N/A |
| Revelation Biosciences, Inc. (REVB)vs › | $2.97M | N/A | N/A | N/A | N/A |
| Adagio Medical Holdings, Inc. (ADGM)vs › | $2.97M | -7.53x | 56.70x | 56.70x | 56.70x |
| FibroBiologics, Inc. Common Stock (FBLG)vs › | $2.49M | -81.61x | N/A | N/A | N/A |
| Jaguar Health, Inc. (JAGX)vs › | $2.47M | 673.25x | 673.25x | 673.25x | 673.25x |
| BioRestorative Therapies, Inc. (BRTX)vs › | $3.07M | N/A | N/A | N/A | N/A |
| Onconetix, Inc. (ONCO)vs › | $2.39M | -8.45x | N/A | N/A | N/A |
Interest Coverage
-4606.4x
Debt/Equity
0.14
Current Ratio
0.82
Formula: Interest Coverage = EBIT / Interest Expense
Reference ranges:
Note: Interest coverage should be compared with historical interest expense, operating income, and industry capital structure.
Interest Coverage = EBIT / Interest Expense
The interest coverage ratio measures operating earnings relative to interest expense.
Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute
| DATE | INTEREST COVERAGE RATIO |
|---|---|
| 2026-03-31 | -2025.86x |
| 2025-12-31 | -2402.04x |
| 2025-09-30 | -1415111.00x |
| 2025-03-31 | -79.98x |
| 2024-12-31 | -28.66x |
| 2024-09-30 | -231.59x |
| 2024-06-30 | -487.63x |
| 2024-03-31 | -672.01x |
| 2023-12-31 | -13.09x |
| 2023-09-30 | -491.40x |
| 2023-06-30 | -1007.59x |
| 2023-03-31 | -719.21x |
| 2022-12-31 | -21.41x |
| 2022-09-30 | -52.93x |
| 2022-06-30 | -61.15x |
| 2022-03-31 | -61.98x |
| 2021-12-31 | -49.71x |
| 2021-09-30 | -19.22x |
| 2021-06-30 | -1.35x |
| 2021-03-31 | -1.10x |
| 2020-12-31 | -1.61x |
| 2020-09-30 | -1.54x |
| 2020-06-30 | -0.66x |
| 2020-03-31 | -0.76x |
| 2019-12-31 | -1.39x |
| 2019-09-30 | -3.37x |
